We are Kiadis, a biopharmaceutical company who focusses on the treatments of blood cancers aiming to make bone marrow transplantations, safer and more efficient.
In support of our rapid growth and the expansion of our portfolio into innovative NK cell therapies, we are strengthening our Product Development team with a Project Manager – NK Cell Program, based on the East Coast, in the United States.
As the Project Manager you work directly for the Product Development Leader. You help the Product Development team on creating and tracking the integrated clinical development, CMC and regulatory product strategy, specifically for the Kiadis NK cell platform. You ensure that the Product Development Plan and Key Event Maps are effectively managed, with an initial focus on CMC given the state of the Kiadis NK cell program. Day to day you will:
The ideal candidate
We are looking for someone that has the following requirements:
What we offer
A challenging position in an innovative, fast growing, biotechnology company. Working in a fast-paced dynamic environment brings the opportunity to make your own mark within the organization.
You will be rewarded a competitive remuneration package, the opportunity for personal development and to contribute to make a huge difference for patients.
Kiadis Pharma is an equal opportunity employer. We understand that diversity of thought, culture and background will help us do the best for our patients. We prohibit unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital and veteran status.
Note to External Recruiters: All candidate activity and open positions are managed strictly through our Talent Acquisition Department. We kindly requests that recruiters not contact employees/hiring managers directly in an attempt to solicit business and present candidates. Submission of unsolicited resumes prior to an agreement set in place between the Talent Acquisition Department and the recruiting agency will not create any implied obligation.
Kiadis Pharma is a clinical stage biopharmaceutical company developing innovative products to make bone marrow transplantations safer and more effective for patients. Kiadis Pharma believes that its innovative products have the potential to address the current risks and limitations connected with allogeneic hematopoietic stem cell transplantation (HSCT), thereby meeting a significant unmet medical need with its products.More about Kiadis Pharma